Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 22,004 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Healthy
Interventions: Maya App; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 22 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Leadership, Personality
Interventions: evaluate the impact of organizational interventions for physician development on wellbeing; Other
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Craniectomy, Trephined Syndrome, Traumatic Brain Injury (TBI) Patients, Ischemic Stroke
Interventions: External Cranial Prosthesis; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Suicidal Ideation, Eating Disorder Symptom
Interventions: Reconnecting to Internal Sensations and Experiences, Healthy Habits; Behavioral
Lead sponsor: Auburn University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Diet, High-Fat, Circadian Rhythm
Interventions: High-Fat Diet, Low-Fat Diet; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Metastatic Bone Disease
Interventions: Internal Fixation, Resection and reconstruction; Procedure
Lead sponsor: Michelle Ghert, MD; Other
Eligibility: 18 Years and older
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 7
States / cities: Aurora, Colorado • Fort Wayne, Indiana • Baltimore, Maryland + 4 more

Conditions: Abdominal Trauma
Interventions: Nutrition Supplement; Dietary Supplement
Lead sponsor: Duke University; Other
Eligibility: 15 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Painful Diabetic Neuropathy
Interventions: Naltrexone, Placebo; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Sepsis, Acute Lung Injury(ALI)
Interventions: Not listed
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
Interventions: TORL-1-23, Pegfilgrastim (drug); Drug
Lead sponsor: TORL Biotherapeutics, LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 26
States / cities: Phoenix, Arizona • Tucson, Arizona • Duarte, California + 22 more

Conditions: Kidney Tumor, Renal Benign Neoplasm, Renal Malignant Tumor
Interventions: Not listed
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Triple Negative Breast Cancer
Interventions: Carboplatin, Paclitaxel, Pembrolizumab; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Esophageal Cancer, Head and Neck Cancer, Lung Cancer, Precancerous Condition
Interventions: immunohistochemistry staining method, laboratory biomarker analysis, sputum cytology, biopsy; Other · Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 21 Years to 90 Years
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Breast Carcinoma, Breast Ductal Carcinoma in Situ
Interventions: Patient Navigation, Questionnaire; Behavioral · Other
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Parent-Child Relations, Development, Infant, Parenting, Development, Child
Interventions: Circle of Security Parenting, Little Talks; Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 8 Months and older
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: College Park, Maryland • Bethlehem, Pennsylvania

Conditions: NSCLC, Stage I
Interventions: Pembrolizumab; Drug
Lead sponsor: Greg Durm, MD; Other
Eligibility: 18 Years and older
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 13
States / cities: Tampa, Florida • Chicago, Illinois • Indianapolis, Indiana + 10 more

Conditions: Metastatic Cancer
Interventions: Palliative radiotherapy; Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Diffuse Pleural Mesothelioma, Gastroesophageal Carcinoma, Urothelial Carcinoma
Interventions: BMS-986504, Ipilimumab, Nivolumab, 5-FU, Leucovorin, Oxaliplatin, Gemcitabine, Platinum; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Surgery, Pain, Post Operative
Interventions: NSAID, Opioid, Acetaminophen, Ibuprofen; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 12 Years to 20 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 9
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 6 more

Conditions: Respiratory Syncytial Virus (RSV)
Interventions: RSVpreF Vaccine; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 17
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Decatur, Georgia + 8 more

Conditions: Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms, Pancreatic Neoplasm, Colorectal Neoplasms
Interventions: Sofe-M, bevacizumab, carboplatin, Itraconazole, pembrolizumab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 575 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 11
States / cities: Scottsdale, Arizona • La Jolla, California • Atlanta, Georgia + 7 more

Conditions: Locally Advanced or Metastatic Solid Tumors
Interventions: ANS014004; Drug
Lead sponsor: Avistone Biotechnology Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 8
States / cities: San Diego, California • Denver, Colorado • Orlando, Florida + 5 more

Conditions: ADHD, Autism Spectrum Disorder
Interventions: Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.; Drug
Lead sponsor: Daniel Coury; Other
Eligibility: 4 Years to 17 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 11
States / cities: Irvine, California • Los Angeles, California • Portland, Maine + 8 more

Conditions: Stimulant Use, Human Immunodeficiency Virus (HIV), Depression
Interventions: ARTEMIS, Contingency management for Antiretroviral (ARV) adherence; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 59 Years
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

Identification of Biomarkers for Stress Vulnerability and Resilience

Leadership Training Affect Physician Career Satisfaction

External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients

Pilot of Reconnecting to Internal Sensations and Experiences in Undergraduates

Food and Circadian Timing

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

Personalized Nutrition to Improve Recovery in Trauma

Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy

Recovery of Physical Function After Critical Illness In Older Adults

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors

NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Hands and Hearts Together

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial

A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

AWARE: Management of ADHD in Autism Spectrum Disorder

Project neuroARTEMIS